FDA
-
-
-
-
-
-
-
Traws Pharma Reports Third Quarter 2025 Results and Business Highlights
-
-
-
-
-
-
-
Traws Pharma Reports Second Quarter 2025 ResultsĀ and Business Highlights
-
-
-
-
-
-
-
Traws Pharma to Host Investor Event on Bird Flu and COVID Product Candidates Virtual Event to be Held on Monday, March 31, 2025 at 10:00 AM ET
-
-
-
-
-
-
-
Traws Pharma (TRAW) Reports Positive Results from An Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

